Equity Incentive Plan (Details) - USD ($) $ / shares in Units, $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Oct. 31, 2021 |
|
| Equity Incentive Plan (Details) [Line Items] | ||||
| Shares issued (in Shares) | 2,166,667 | 10,000,000 | ||
| Fair value of stock option (in Dollars per share) | $ 1.19 | $ 1.65 | ||
| Intrinsic value options exercised | $ 0.1 | $ 0.9 | ||
| Aggregate intrinsic value | 3.1 | $ 2.9 | ||
| Share-based compensation | $ 2.8 | |||
| Weighted average requisite service period | 2 years 6 months | |||
| Aggregate intrinsic value | $ 0.4 | |||
| Stock-based compensation for RSU granted and outstanding | $ 0.2 | |||
| Stock based compensation for stock options, description | the Company granted 727,922 stock options to the Chief Executive Officer (“CEO”) under the 2020 Plan with an exercise price of $3.00 per share. The options vest based on the CEO’s continued service in addition to the following terms: ● 317,688 options vest in full when the closing price of the Company’s common stock reaches or exceeds $9.00 per share for a minimum of 20 out of 30 trading days after the Company becomes listed on the New York Stock Exchange or Nasdaq. These options expire on March 3, 2031. ● 46,273 options vest in full when the closing price of the Company’s common stock reaches or exceeds $9.00 per share for 20 out of 30 trading days after the Company becomes listed on the New York Stock Exchange or Nasdaq. Since the listing on Nasdaq, these options expire on March 22, 2031, instead of 2026. ● 363,961 options vest in full when the closing price of the Company’s common stock reaches or exceeds $13.50 per share for 20 out of 30 trading days after the Company becomes listed on the New York Stock Exchange or Nasdaq. Since the listing on Nasdaq, these options expire on March 22, 2031, instead of 2026. | |||
| Share based compensation fair value, description | The Company’s assumptions, for the options expiring on March 3, 2031, for expected volatility, closing price and risk-free rate were 50.0%, $3.00 and 0.77%, respectively. For the options expiring on March 22, 2031, the assumptions for expected volatility, closing price and risk-free rate were 50.0%, $3.00 and 0.87%, respectively. The aggregate estimated fair value of the options was $0.4 million. The Company recognized $0.1 million in stock-based compensation expense for the year ended December 31, 2022. As of December 31, 2022, there was $0.2 million of unrecognized compensation cost which the Company plans to recognize over a weighted average period of 1.3 years. | |||
| Common Stock [Member] | ||||
| Equity Incentive Plan (Details) [Line Items] | ||||
| Shares issued (in Shares) | 267,430 | |||
| 2020 Equity incentive Plan [Member] | ||||
| Equity Incentive Plan (Details) [Line Items] | ||||
| Options contractual life | 10 years | |||
| Number of shares equal percentage | 5.00% | |||
| RSU [Member] | ||||
| Equity Incentive Plan (Details) [Line Items] | ||||
| Weighted average requisite service period | 6 months | |||